Table: Fractale - 9-MTH group results

ADR Biomedical Holdings

03/02/2020 06:00

Feb 3 (Reuters)- 
             Fractale Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            623 mln              1.85             2.80     
                 (-66.4 pct)                          (+45.5 pct) 
  Operating         7 mln              285 mln          440 mln   
                 (-97.4 pct)                          (+50.0 pct) 
  Recurring      loss 29 mln           203 mln          390 mln   
                                                      (+90.8 pct) 
  Net            loss 30 mln           222 mln          380 mln   
                                    (+169.7 pct)      (-35.9 pct) 
  EPS           loss 4.53 yen         33.12 yen        56.61 yen  
  Ann Div                             20.00 yen        20.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Fractale Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T